Prevention and treatment of allergic diarrhea
View Patent ↗Bifidobacterium breve CNCM I-3865 (NCC2950), a composition comprising Bifidobacterium breve CNCM I-3865 (NCC2950), and the use of Bifidobacterium breve CNCM I-3865 (NCC2950) in the prevention or treatment of allergic diarrhoea are provided. The Bifidobacterium breve CNCM I-3865 (NCC2950) can be in a non-replicating form and can be administered to at least partially treat allergic diarrhoea or at least partially reduce the risk of developing allergic diarrhoea.
1. A method for the treatment or prevention of allergic diarrhoea comprising the step of orally administering a composition comprising between 10 3 and 10 12 cfu of Bifidobacterium breve CNCM I-3865 (NCC2950) per g of the composition to an individual requiring same.
2. The method according to claim 1 , wherein the composition is selected from the group consisting of a medicament, a therapeutic nutritional composition, an infant feeding formula, a follow-on formula, a growing-up milk, a food product, an animal food, a nutraceutical, a drink, and a food additive.
3. The method according to claim 1 , wherein the composition comprises hydrolyzed proteins.
4. The method according to claim 1 , wherein the composition comprises the Bifidobacterium breve CNCM I-3865 (NCC2950) in an amount equivalent to between 10 7 and 10 11 cfu/g of the composition.
5. The method according to claim 1 , wherein in the composition at least 95% of the Bifidobacterium breve CNCM I-3865 (NCC2950) are non-replicating.
6. The method according to claim 1 , wherein the composition comprises at least one prebiotic in an amount of from 0.3 to 6% by weight of the composition.
7. The method according to claim 1 , wherein the composition is a supplement and comprises from 10 4 to 10 12 cfu of the Bifidobacterium breve CNCM I-3865 (NCC2950) per unit dose.
8. The method in accordance with claim 1 wherein the individual is an infant.
9. The method in accordance with claim 1 wherein the individual is a young child.
10. A method for treating allergic diarrhoea comprising orally administering a composition comprising between 10 3 and 10 12 cfu of Bifidobacterium breve CNCM I-3865 (NCC2950) per g of the composition to an individual having the allergic diarrhoea.
11. The method in accordance with claim 10 , wherein the composition is in a form selected from the group consisting of a medicament, a therapeutic nutritional composition, an infant feeding formula, a follow-on formula, a growing-up milk, a food product, an animal food, a nutraceutical, a drink, and a food additive.
12. The method in accordance with claim 10 further comprising causing at least 95% of the Bifidobacterium breve CNCM I-3865 (NCC2950) to be non-replicating before administering the composition.
13. The method in accordance with claim 10 further comprising preparing the Bifidobacterium breve CNCM I-3865 (NCC2950) for addition to the composition by performing a step selected from the group consisting of freeze-drying the Bifidobacterium breve CNCM I-3865 (NCC2950), spray-drying the Bifidobacterium breve CNCM I-3865 (NCC2950), and encapsulating the Bifidobacterium breve CNCM I-3865 (NCC2950).
14. The method in accordance with claim 10 wherein the composition comprises hydrolyzed proteins.
15. The method in accordance with claim 10 wherein the individual is an infant.
16. The method in accordance with claim 10 wherein the individual is a young child.